Radigene develops a novel imaging technology that makes therapeutic cells visible inside the body. By combining genetic reporters with PET imaging, Radigene enables real-time, whole-body tracking of advanced cell therapies, supporting safer development and faster clinical translation.
Proven in vivo imaging. Radigene has generated in vivo imaging data showing our reporter gene can reveal where engineered cells go in the body, the foundation for letting clinicians track CAR-T and other living medicines by scan.
Won the Gulliver Challenge. Radigene was awarded the Gulliver Challenge Innovation prize, an early external endorsement of our reporter-gene approach to imaging cell therapies in patients.
First collaboration with the Peperzak lab. The startup has established our first research collaboration with the Peperzak lab (UMC Utrecht), strengthening our preclinical imaging work and establishing a proof-of-concept for our product.
Radigene won at the Gulliver Awards in 2026. Read more here.
